Tech Company Financing Transactions
Bio Theranostics Funding Round
Bio Theranostics closed a $20 million financing round on 3/31/2016. Investors included Canepa Advanced Healthcare Fund, HealthQuest Capital and MVM Life Science Partners.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$20,000,200
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9640 Towne Centre Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Hardison
Chief Financial Officer
Gail Sloan
Chief Scientific Officer
Catherine Schnabel
VP - General Counsel
Karla Kelly
VP - Marketing
Debbie Ledet
VP - Operations
Debra Hadley
VP - Sales
Matt Sargent
Browse more venture capital transactions:
Prev: 3/31/2016: Change Collective venture capital transaction
Next: 3/31/2016: Datarista venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs